End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.96 CNY | +3.70% | +6.54% | -28.38% |
May. 16 | Hualan Biological Engineering's Blood Centers Get License to Operate | MT |
Apr. 24 | Hualan Group Co., Ltd. Proposes Final Dividend for 2023 | CI |
Sales 2022 | 845M 117M | Sales 2023 | 701M 97.02M | Capitalization | 1.86B 257M |
---|---|---|---|---|---|
Net income 2022 | 54M 7.48M | Net income 2023 | 19M 2.63M | EV / Sales 2022 | 1.58 x |
Net cash position 2022 | 653M 90.36M | Net cash position 2023 | 427M 59.08M | EV / Sales 2023 | 2.04 x |
P/E ratio 2022 |
36.5
x | P/E ratio 2023 |
96.2
x | Employees | 2,546 |
Yield 2022 |
0.26% | Yield 2023 |
0.1% | Free-Float | 60.61% |
1 day | +3.70% | ||
1 week | +6.54% | ||
Current month | +7.69% | ||
1 month | +14.43% | ||
3 months | +30.61% | ||
6 months | -28.72% | ||
Current year | -28.38% |
Managers | Title | Age | Since |
---|---|---|---|
Hai Liang Mo
CEO | Chief Executive Officer | 46 | 16-12-31 |
Jia Li
DFI | Director of Finance/CFO | 51 | 12-05-08 |
Xiang Lei
CHM | Chairman | 67 | 12-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhao Mei Chi
BRD | Director/Board Member | 53 | 22-01-20 |
Gong Zhang Yuan
BRD | Director/Board Member | 50 | 20-05-31 |
Xiang Lei
CHM | Chairman | 67 | 12-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 8.96 | +3.70% | 6,282,937 |
24-05-16 | 8.64 | +5.11% | 6,583,800 |
24-05-15 | 8.22 | +1.36% | 3,907,700 |
24-05-14 | 8.11 | +1.00% | 2,386,000 |
24-05-13 | 8.03 | -4.52% | 3,168,186 |
End-of-day quote Shenzhen S.E., May 16, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-28.38% | 182M | |
+4.15% | 4.72B | |
+28.79% | 2.12B | |
+33.46% | 2.06B | |
+40.60% | 1.95B | |
-14.51% | 1.53B | |
+63.12% | 1.09B | |
+1.11% | 1.01B | |
+34.21% | 955M | |
+9.98% | 952M |
- Stock Market
- Equities
- 301027 Stock